Jacobs Levy Equity Management’s Achieve Life Sciences ACHV Stock Holding History

Jacobs Levy Equity Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-34	Closed	-$165K	–	789
2015 Q3	$165K	Sell	34 -35	-51%	-$211K	﹤0.01%	726
2015 Q2	$354K	Buy	69 +52	+306%	+$258K	0.01%	626
2015 Q1	$82K	Sell	17 -43	-72%	-$211K	﹤0.01%	752
2014 Q4	$304K	Buy	60 +7	+13%	+$34.2K	0.01%	681
2014 Q3	$310K	Buy	+53	New	+$368K	0.01%	672
2014 Q2	–	Sell	-9	Closed	-$241K	–	824
2014 Q1	$241K	Buy	9 +2	+29%	+$49.1K	﹤0.01%	789
2013 Q4	$136K	Sell	7 -6	-46%	-$105K	﹤0.01%	893
2013 Q3	$262K	Buy	13 +8	+160%	+$166K	﹤0.01%	821
2013 Q2	$105K	Buy	+5	New	+$112K	﹤0.01%	934

Other funds holding ACHV

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Abingworth London, United Kingdom $304M AUM 95.02% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

Alambic Investment Management Belvedere, California $9.12M AUM 34.55% 1-Year Est. Return

Jacobs Levy Equity Management's ACHV Position: Q4 2015 in Review

Jacobs Levy Equity Management sold out of Achieve Life Sciences (ACHV) in Q4 2015, closing a stake of 34 shares — an estimated $165K sold.

Jacobs Levy Equity Management first reported a position in ACHV in Q2 2013 and held it in 9 quarters. The position peaked at $354K in Q2 2015. 47 funds tracked by Wall St. Rank hold ACHV as of Q4 2015.

Jacobs Levy Equity Management reported no remaining Achieve Life Sciences position as of Q4 2015 after selling out during the quarter.
Jacobs Levy Equity Management sold 34 Achieve Life Sciences shares in Q4 2015, an estimated $165K.
Jacobs Levy Equity Management first reported a position in Achieve Life Sciences in Q2 2013 and held it in 9 quarters.
Jacobs Levy Equity Management's Achieve Life Sciences position peaked at $354K in Q2 2015.
47 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2015.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2015, filed 16 Feb 2016.